Lantern Pharma Inc (LTRN) — Defensive Interval Ratio

Latest as of September 2025: 359 days

Lantern Pharma Inc (LTRN) has a Defensive Interval Ratio of 359 days as of September 2025. Defensive assets of $3.97 Million (cash $-, short-term investments $3.97 Million, receivables $-) cover 359 days of daily cash needs of $11.07K/day. See LTRN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

359 days
Days of operational coverage

Defensive Assets

$3.97 Million
Cash + ST Investments + Receivables

Daily Cash Need

$11.07K
Current Liabilities ÷ 365

Current Liabilities

$4.04 Million
USD

Lantern Pharma Inc Defensive Interval Ratio (2020–2024)

This chart shows how Lantern Pharma Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 359 days, meaning defensive assets of $3.97 Million can fund 359 days of operations without new revenue. See Lantern Pharma Inc (LTRN) net asset quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Lantern Pharma Inc (2020–2024)

The table below presents the year-by-year Defensive Interval Ratio for Lantern Pharma Inc from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Lantern Pharma Inc.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 1399 days $16.60 Million $11.87K/day $- $16.50 Million ▼ -1358 days
2023 2756 days $20.22 Million $7.34K/day $- $19.36 Million ▲ +332 days
2022 2424 days $18.59 Million $7.67K/day $- $17.99 Million ▼ -617 days
2021 3041 days $19.38 Million $6.37K/day $- $19.20 Million ▲ +3041 days
2020 0 days $0.00 $1.51K/day $- $0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)